Prostate Cancer Care Declined During the COVID-19 Pandemic
Access to medical care for men with prostate cancer was sharply reduced last year during the COVID-19 pandemic, according to... Read More
Vast Majority of Men With Early-Stage Prostate Cancer Die From Other Causes
Men with early-stage prostate cancer (PCa) are far more likely to die from other causes, especially noncancer causes such as... Read More
Black Men Report More Regret Over Prostate Cancer Treatment Decisions
Black men are more likely to report decisional regret over localized prostate cancer (PCa) treatment than men of other races,... Read More
Prostate Cancer Treatment Considerations in Patients of Low Socioeconomic Status
Men of low socioeconomic status (SES) are more likely to present with metastases when they are diagnosed with prostate cancer... Read More
Prostate Cancer Mortality, Treatment in the US Differ By Region
Prostate cancer (PCa) epidemiology and management in the United States have been found to differ across regions. It is well... Read More
Psychosocial Concerns Common After Prostate Cancer Treatment
Psychosocial problems that adversely affect quality of life are common among men after receiving treatment for prostate cancer (PCa), and... Read More
Prostate Cancer Salvage Combo Benefits Confirmed
Final results of a phase 3 trial confirm the progression-free survival (PFS) benefit of adding short-term androgen suppression to radiotherapy... Read More
Neoadjuvant Combo Reduces Volume of High-Risk Prostate Tumors
Neoadjuvant therapy that combines abiraterone acetate plus prednisone (AAP) and leuprolide prior to radical prostatectomy significantly reduces tumor size in... Read More
Dementia Not Linked to ADT for Prostate Cancer
New research may ease concerns that androgen deprivation therapy (ADT) contributes to dementia in patients with prostate cancer (PCa). Read... Read More
Study: Private Payer Coverage of Prostate MRI Lagging
Prostate magnetic resonance imaging (MRI) has becoming increasingly important in diagnosing and managing prostate cancer (PCa), but private payer coverage of prostate... Read More